Objective: To examine provision of direct-to-patient medication abortion during COVID-19 by United States family physicians through a clinician-supported, asynchronous online service, Aid Access. Study Design: We analyzed data from United States residents in New Jersey, New York, and Washington who requested medication abortion from 3 family physicians using the online service from Aid Access between April and November 2020. This study seeks to examine individual characteristics, motivations, and geographic locations of patients receiving abortion care through the Aid Access platform. Results: Over 7 months, three family physicians using the Aid Access platform provided medication abortion care to 534 residents of New Jersey, New York, and Washington. There were no demographic differences between patients seeking care in these states. A high percentage (85%) were less than 7 weeks gestation at the time of their request for care. The reasons patients chose Aid Access for abortion services were similar regardless of state residence. The majority (71%) of Aid Access users lived in urban areas. Each family physician provided care to most counties in their respective states. Among those who received services in the three states, almost one-quarter (24%) lived in high Social Vulnerability Index (SVI) counties, with roughly one-third living in medium-high SVI counties (33%), followed by another quarter (26%) living in medium-low SVI counties. Conclusions: Family physicians successfully provided medication abortion in three states using asynchronous online consultations and medications mailed directly to patients. Implications: Primary care patients are requesting direct-to-patient first trimester abortion services online. By providing abortion care online, a single provider can serve the entire state, thus greatly increasing geographic access to medication abortion.

No abstract

Introduction:To overcome obstacles to delivering medication abortion services during the COVID-19 pandemic, clinics and providers implemented new medication abortion service models not requiring in-person care. This study identifies organizational factors that promoted successful implementation of telehealth and adoption of "no test" medication abortion protocols. Methods:We conducted 21 semi-structured, in-depth interviews with healthcare providers and clinic administrators implementing clinician-supported telehealth abortion during the COVID pandemic. We selected 15 clinical sites to represent four different practice settings: independent primary care practices, online medical services, specialty family planning clinics, and primary care clinics within multispecialty health systems. The Consolidated Framework for Implementation Research (CFIR) guided our thematic analysis.Results: Successful implementation of telehealth abortion included access to formal and informal inter-organizational networks, including professional organizations and informal mentorship relationships with innovators in the field; organizational readiness for implementation, such as having clinic resources available for telehealth services like functional electronic health records and options for easy-to-use virtual patient-provider interactions; and motivated and effective clinic champions. Conclusions:In response to the need to offer remote clinical services, four different practice settings types leveraged key operational factors to facilitate successful implementation of telehealth abortion. Information from this study can inform implementation strategies to support the dissemination and adoption of this model.Implications-Examples of successfully implemented telehealth medication abortion services provide a framework that can be used to inform and implement similar patient-centered telehealth models in diverse practice settings.

No abstract

PURPOSE Established models of reproductive health service delivery were disrupted by the coronavirus disease 2019 pandemic. This study examines rapid innovation of remote abortion service operations across health care settings and describes the use of telehealth consultations with medications delivered directly to patients. METHODSWe conducted semi-structured interviews with 21 clinical staff from 4 practice settings: family planning clinics, online medical services, and primary care practices-independent or within multispecialty health systems. Clinicians and administrators described their telehealth abortion services. Interviews were recorded, transcribed, and analyzed. Staff roles, policies, and procedures were compared across practice settings.RESULTS Across all practice settings, telehealth abortion services consisted of 5 operational steps: patient engagement, care consultations, payment, medication dispensing, and follow-up communication. Online services and independent primary care practices used asynchronous methods to determine eligibility and complete consultations, resulting in more efficient services (2-5 minutes), while family planning and health system clinics used synchronous video encounters requiring 10-30 minutes of clinician time. Family planning and health system primary care clinics mailed medications from clinic stock or internal pharmacies, while independent primary care practices and online services often used mailorder pharmacies. Online services offered patients asynchronous follow-up; other practice settings scheduled synchronous appointments.CONCLUSIONS Rapid innovations implemented in response to disrupted in-person reproductive health care included remote medication abortion services with telehealth assessment/follow-up and mailed medications. Though consistent operational steps were identified across health care settings, variation allowed for adaptation of services to individual sites. Understanding remote abortion service operations may facilitate dissemination of a range of patient-centered reproductive health services.

Telemedicine appears to be a beneficial, patient-centered approach to critically needed first-trimester abortion services.

No abstract

Context: Abortion care using novel no-test telemedicine protocols and delivery of abortion pills by mail provides an historic opportunity for primary care to include medication abortion as part of the comprehensive reproductive care provided to patients. Because in-person care in the clinical setting was the only model, it is unknown whether communication practices by clinicians warrants a shift with telemedicine abortion. Objective: to evaluate best practices in patient-provider communication for telemedicine abortion care. Study Design/Analysis: We conducted in-depth interviews and used inductive-deductive constant comparative analysis. A community advisory board guided our interview guide and interpretation of findings. Setting: High-volume reproductive healthcare clinic organization with several satellite locations throughout Washington State. Population Studied: Patients who recently sought either in-clinic or telemedicine medication abortion services with licensed advance practice and family medicine providers. Instrument: Miller's conceptual framework for patient-clinician communication in telemedicine settings shaped the interview guide. Outcome Measures: Decision to choose in-clinic or telemedicine services and experiences with scheduling process, attending the appointment and communication of the clinician. Results: 30 research participants, 20 telemedicine and 10 in-clinic, completed the interview. Telehealth patients reported similar levels of interpersonal connection to their providers as in-clinic patients, including feeling their provider was relatable, supportive, affirming of their decision, not-rushed, empathetic, and an attentive listener. Some telehealth patients reported an enhanced communication experience due to their decreased anxiety and stress from avoiding an in-clinic visit. Both groups of patients understood the plan of care, including how to obtain and take medications, and felt empowered to garner personal and medical support as necessary. All patients relied heavily on printed clinic materials and online resources to answer symptomatic questions during the abortion process. Conclusions: Patients receiving either telemedicine or in-clinic abortion services by primary care providers reported similar interpersonal and medical information communication experiences. Challenging contextual factors reported by some in-clinic patients suggests telehealth as a favorable option for medication abortion care services.